Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcon

This article was originally published in The Tan Sheet

Executive Summary

Firm requests temporary exemption from FDA's final rule requiring use of "tamper-evident" instead of "tamper-resistant" language on OTC packaging. Alcon states in an Oct. 9 citizen petition that it has depleted inventory for 121 packaging components impacted by the reg, which is effective Nov. 6. However, the firm is unable to deplete its inventory of Tears Naturale P.M. Lubricant Eye Ointment "due to the closure of a manufacturing plant and issues related to the timing of transfer of product manufacturing." "Tamper-evident" language will begin appearing on the product tube after February, Alcon says
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091843

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel